ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.4185+10G>A

dbSNP: rs80358104
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001084169 SCV000289793 benign Hereditary breast ovarian cancer syndrome 2024-12-31 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV001281725 SCV000296460 uncertain significance not provided 2020-01-03 criteria provided, single submitter clinical testing
GeneDx RCV000421135 SCV000531311 likely benign not specified 2017-09-25 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Color Diagnostics, LLC DBA Color Health RCV000581043 SCV000683157 likely benign Hereditary cancer-predisposing syndrome 2017-03-23 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000421135 SCV000699115 likely benign not specified 2024-09-03 criteria provided, single submitter clinical testing Variant summary: BRCA1 c.4185+10G>A alters a non-conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.3e-05 in 237410 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.4185+10G>A has been reported in the literature in patients from hereditary breast/ovarian cancer families who underwent clinical BRCA1 screening (Judkins_2005). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Breast And Ovarian Cancer Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 16267036, 34290354). ClinVar contains an entry for this variant (Variation ID: 96927). Based on the evidence outlined above, the variant was classified as likely benign.
Counsyl RCV000083048 SCV000784871 likely benign Breast-ovarian cancer, familial, susceptibility to, 1 2017-01-18 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV000083048 SCV004828655 likely benign Breast-ovarian cancer, familial, susceptibility to, 1 2023-09-17 criteria provided, single submitter clinical testing
Sharing Clinical Reports Project (SCRP) RCV000083048 SCV000115122 benign Breast-ovarian cancer, familial, susceptibility to, 1 2011-09-16 no assertion criteria provided clinical testing
Breast Cancer Information Core (BIC) (BRCA1) RCV000083048 SCV000145008 uncertain significance Breast-ovarian cancer, familial, susceptibility to, 1 2010-12-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.